Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2004 Giugno;48(2) > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2004 Giugno;48(2):76-81

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Rivista di Medicina Nucleare e Imaging Molecolare


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413


eTOC

 

  NUCLEAR MEDICINE AND ONCOLOGY


The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2004 Giugno;48(2):76-81

lingua: Inglese

Position of nuclear medicine techniques in the diagnostic work-up of brain tumors

Del Sole A. 1, Moncayo R. 2, Tafuni G. 3, Lucignani G. 1,4

1 Institute of Radiological Sciences, University of Milan, Italy
2 University of Innsbruck, Innsbruck, Austria
3 IRCCS Ospetabe Maggiore Hospital, Polyclinic of Milan, Italy
4 Unit of Molecular Imaging, Department of Radiation Oncology European Institute of Oncology, Milan, Italy


FULL TEXT  


Although any patient with a suspected brain tumor, either primary or metastatic, should be studied with anatomic imaging modalities such as angiography, computerized tomagraphy (CT) or magnetic resonance imaging (MRI), nuclear medicine techniques are available to further characterize some biological features of brain lesions and help in diagnosis and therapy planning. Bloob-brain-barrier disruption can be easily assessed with single-photon emission tomography (SPET), whereas focal metabolic changes can be better demonstrated by positron emission tomography (PET) as specific radiopharmaceuticals are available to detect changes in glucose utilization and aminoacid uptake with this technique. Expression of specific tumoral antigens is the basis of imaging with radioimmunoscintigraphy, a promising technique that can be applied to brain tumor therapy. The major clinical applications of nuclear medicine in the study of brain tumors — evaluation of the extension of a tumoral mass, differential diagnosis and evaluation of therapy and prognosis — are discussed.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail